Form D · Other Health Care

Ginger.io, Inc.

San Francisco, CA · CIK 0001528050

Offering snapshot reported Aug 11, 2020 · SEC filing

Reported sold
$50.1M
Offering amount: $50.1M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 6, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 11, 2020Initial$50,060,467No comparison12SEC filing
Sep 3, 2019Initial$21,208,750No comparison12SEC filing
Dec 23, 2014Initial$20,000,016No comparison3SEC filing
Nov 28, 2012Initial$6,204,308No comparison4SEC filing
Oct 7, 2011Amendment$1,652,404$489,996vs Aug 19, 201112SEC filing
Aug 19, 2011Initial$1,162,408No comparison7SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-372953

Source: Form D, filed Aug 11, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Bruce Armstrong Director
Sam Brasch Director
Jon Callaghan Director
Molly Coye Director
Russell Glass Director, Executive
David Ibn Ale Director
Steve Kraus Director
Anmol Madan Director, Executive
Ainslie Mayberry Executive
Ryan O'toole Executive
Alex Pentland Director
Ryan Phillips Director
Dave Schulte Director
Karan Singh Executive
Ananthalakshmi Srinivasan Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
116 New Montgomery Street Suite 500
San Francisco, CA, 94105